Literature DB >> 10806174

Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways.

F L Ricciardolo1, M Steinhoff, S Amadesi, R Guerrini, M Tognetto, M Trevisani, C Creminon, C Bertrand, N W Bunnett, L M Fabbri, S Salvadori, P Geppetti.   

Abstract

The protease activated receptor-2 (PAR-2) belongs to a family of G-protein-coupled receptors that are activated by proteolysis. Trypsin cleaves PAR-2, exposing an N-terminal tethered ligand (SLIGRL) that activates the receptor. Messenger RNA (mRNA) for PAR-2 was found in guinea pig airway tissue by reverse transcription-polymerase chain reaction, and PAR-2 was found by immunohistochemistry in airway epithelial and smooth-muscle cells. In anesthetized guinea pigs, trypsin and SLIGRL-NH(2) (given intratracheally or intravenously) caused a bronchoconstriction that was inhibited by the combination of tachykinin-NK(1) and -NK(2) receptor antagonists and was potentiated by inhibition of nitric oxide synthase (NOS). Trypsin and SLIGRL-NH(2) relaxed isolated trachea and main bronchi, and contracted intrapulmonary bronchi. Relaxation of main bronchi was abolished or reversed to contraction by removal of epithelium, administration of indomethacin, and NOS inhibition. PAR-1, PAR-3, and PAR-4 were not involved in the bronchomotor action of either trypsin or SLIGRL-NH(2), because ligands of these receptors were inactive either in vitro or in vivo, and because thrombin (a PAR-1 and PAR-3 agonist) did not show cross-desensitization with PAR-2 agonists in vivo. Thus, we have localized PAR-2 to the guinea-pig airways, and have shown that activation of PAR-2 causes multiple motor effects in these airways, including in vivo bronchoconstriction, which is in part mediated by a neural mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806174     DOI: 10.1164/ajrccm.161.5.9907133

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

1.  Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems.

Authors:  M Saifeddine; B Al-Ani; S Sandhu; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Visceral perception: inflammatory and non-inflammatory mediators.

Authors:  L Bueno; J Fioramonti
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

3.  Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cells.

Authors:  Randolph Corteling; Olivier Bonneau; Stephane Ferretti; Mireille Ferretti; Alexandre Trifilieff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-06-18       Impact factor: 3.000

4.  Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.

Authors:  Silvia Amadesi; Graeme S Cottrell; Lorna Divino; Kevin Chapman; Eileen F Grady; Francisco Bautista; Rustum Karanjia; Carlos Barajas-Lopez; Stephen Vanner; Nathalie Vergnolle; Nigel W Bunnett
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 5.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

6.  Effect of protease-activated receptor 2 activation on single TRPV1 channel activities in rat vagal pulmonary sensory neurons.

Authors:  Qihai Gu; Lu-Yuan Lee
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

7.  Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea.

Authors:  R S Lan; D A Knight; G A Stewart; P J Henry
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

8.  Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers.

Authors:  D Miotto; M D Hollenberg; N W Bunnett; A Papi; F Braccioni; P Boschetto; F Rea; A Zuin; P Geppetti; M Saetta; P Maestrelli; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

9.  Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.

Authors:  Michela Rigoni; Marcello Trevisani; David Gazzieri; Riccardo Nadaletto; Michele Tognetto; Christophe Creminon; John B Davis; Barbara Campi; Silvia Amadesi; Pierangelo Geppetti; Selena Harrison
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.

Authors:  Toshiaki Sendo; Yoshinori Itoh; Takeshi Goromaru; Tomoko Sumimura; Mami Saito; Keisei Aki; Takahisa Yano; Ryozo Oishi
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.